Next Article in Journal
Abnormal Plasma Cell Disorders in Refinery Waste Workers
Next Article in Special Issue
Albuminuria Increases All-Cause Mortality in Japanese Patients with Type 2 Diabetes Mellitus
Previous Article in Journal
Simple Scores of Fibrosis and Mortality in Patients with NAFLD: A Systematic Review with Meta-Analysis
Previous Article in Special Issue
Heat Shock Protein 70 Gene Single Nucleotide Polymorphism and Diabetic Foot Ulcer. Is There Any Relationship?
Article Menu
Issue 8 (August) cover image

Export Article

Open AccessArticle
J. Clin. Med. 2018, 7(8), 220; https://doi.org/10.3390/jcm7080220

Mitochondrial DNA Haplogroup JT is Related to Impaired Glycaemic Control and Renal Function in Type 2 Diabetic Patients

1
Service of Endocrinology, University Hospital Doctor Peset, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO), 46017 Valencia, Spain
2
Department of Biochemistry and Molecular and Cell Biology, University of Zaragoza, 50013 Zaragoza, Spain
3
Instituto de Investigación Sanitaria de Aragón (IIS Aragón), 50013 Zaragoza, Spain
4
Centro de Investigaciones Biomédicas En Red de Enfermedades Raras (CIBERER), 50013 Zaragoza, Spain
5
CIBERehd-Department of Pharmacology and Physiology, University of Valencia, 46010 Valencia, Spain
6
Fundación ARAID, 50018 Zaragoza, Spain
*
Authors to whom correspondence should be addressed.
Received: 17 July 2018 / Revised: 13 August 2018 / Accepted: 14 August 2018 / Published: 16 August 2018
(This article belongs to the Special Issue Type 2 Diabetes: Update on Pathophysiology and Treatment)
Full-Text   |   PDF [1136 KB, uploaded 16 August 2018]   |  

Abstract

The association between mitochondrial DNA (mtDNA) haplogroup and risk of type 2 diabetes (T2D) is undetermined and controversial. This study aims to evaluate the impact of the main mtDNA haplogroups on glycaemic control and renal function in a Spanish population of 303 T2D patients and 153 healthy controls. Anthropometrical and metabolic parameters were assessed and mtDNA haplogroup was determined in each individual. Distribution of the different haplogroups was similar in diabetic and healthy populations and, as expected, T2D patients showed poorer glycaemic control and renal function than controls. T2D patients belonging to the JT haplogroup (polymorphism m.4216T>C) displayed statistically significant higher levels of fasting glucose and HbA1c than those of the other haplogroups, suggesting a poorer glycaemic control. Furthermore, diabetic patients with the JT haplogroup showed a worse kidney function than those with other haplogroups, evident by higher levels of serum creatinine, lower estimated glomerular filtration rate (eGFR), and slightly higher (although not statistically significant) urinary albumin-to-creatinine ratio. Our results suggest that JT haplogroup (in particular, change at position 4216 of the mtDNA) is associated with poorer glycaemic control in T2D, which can trigger the development of diabetic nephropathy. View Full-Text
Keywords: type 2 diabetes mellitus; mitochondrial haplogroup; mtDNA; nephropathy; glycemic control type 2 diabetes mellitus; mitochondrial haplogroup; mtDNA; nephropathy; glycemic control
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Diaz-Morales, N.; Lopez-Domenech, S.; Iannantuoni, F.; Lopez-Gallardo, E.; Sola, E.; Morillas, C.; Rocha, M.; Ruiz-Pesini, E.; Victor, V.M. Mitochondrial DNA Haplogroup JT is Related to Impaired Glycaemic Control and Renal Function in Type 2 Diabetic Patients. J. Clin. Med. 2018, 7, 220.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
J. Clin. Med. EISSN 2077-0383 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top